Stick To The Plan – But Be Ready To Change
An Interview With ‘Rising Leader’ Christophe Bancel, CEO Of TISSIUM
Executive Summary
Know your strengths, surround yourself with experts and ensure your solution “does what it says on the tin.” These are among the guiding principles of Christophe Bancel, co-founder of France’s biopolymer innovator TISSIUM, a health care start-up on the cusp of commercialization.
You may also be interested in...
Novel Tissue Recon Surgery Without The Trauma
With a fairly unlimited range of potential tissue repair applications, polymer device innovator Tissium can pursue a “relatively open” business model, CEO Christophe Bancel told In Vivo.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.